← back to search

Deepak Srivastava

QB3 · US
Area of research
Molecular Biology · Materials Chemistry
Research interest
Research interests include Congenital heart defects research, Carbon Nanotubes in Composites, Congenital Heart Disease Studies, and Pluripotent Stem Cells Research.
h-index
106
citations
48,029
works
736
NIH funding
$3.2M
primary concept
email

Recent publications

The oligogenic inheritance test GCOD detects risk genes and their interactions in congenital heart defects.
2026cited by 0position: contributordoi
Author Correction: Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.
2026cited by 0position: contributordoi
Genome-wide CRISPRi screen identifies basigin loss as protective in cardiac hypoxia
2026cited by 0position: contributordoi
Genomic analysis of 11,555 probands identifies 60 dominant congenital heart disease genes
Proceedings of the National Academy of Sciences 2025cited by 18position: middledoi
The maternal X chromosome affects cognition and brain ageing in female mice
Nature 2025cited by 15position: middledoi
The maternal X chromosome affects cognition and brain ageing in female mice.
2025cited by 13position: contributordoi
Recessive genetic contribution to congenital heart disease in 5,424 probands
Proceedings of the National Academy of Sciences 2025cited by 10position: middledoi
Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21.
2025cited by 2position: contributordoi
A microphysiological system for screening lipid nanoparticle-mRNA complexes predicts in vivo heart transfection efficacy.
2025cited by 1position: contributordoi
MitoScribe single-cell molecular recorder logs graded signaling dynamics into mitochondrial DNA
2025cited by 0position: contributordoi
Uncovering Developmental Origins of Aortic Valve Disease
JACC: Basic to Translational Science 2025cited by 0position: contributordoi
Chromatin remodelling drives immune cell–fibroblast communication in heart failure
Nature 2024cited by 97position: lastdoi
Chromatin remodelling drives immune cell-fibroblast communication in heart failure.
2024cited by 84position: contributordoi
A genome-wide CRISPR screen identifies BRD4 as a regulator of cardiomyocyte differentiation.
2024cited by 11position: contributordoi
Human spinal interneurons repair the injured spinal cord through synaptic integration
2024cited by 8position: contributordoi
Improved Cardiac Function in Postischemic Rats Using an Optimized Cardiac Reprogramming Cocktail Delivered in a Single Novel Adeno-Associated Virus.
2023cited by 16position: contributordoi
Contribution of Previously Unrecognized RNA Splice-Altering Variants to Congenital Heart Disease
Circulation Genomic and Precision Medicine 2023cited by 16position: middledoi
A Mesp1-dependent developmental breakpoint in transcriptional and epigenomic specification of early cardiac precursors.
2023cited by 14position: contributordoi
Contribution of Previously Unrecognized RNA Splice-Altering Variants to Congenital Heart Disease.
2023cited by 14position: contributordoi
Oligogenic Architecture of Rare Noncoding Variants Distinguishes 4 Congenital Heart Disease Phenotypes
Circulation Genomic and Precision Medicine 2023cited by 11position: middledoi
The multi-lineage transcription factor ISL1 controls cardiomyocyte cell fate through interaction with NKX2.5.
2023cited by 10position: contributordoi
Single Cell Multimodal Analyses Reveal Epigenomic and Transcriptomic Basis for Birth Defects in Maternal Diabetes.
2023cited by 10position: contributordoi
Oligogenic Architecture of Rare Noncoding Variants Distinguishes 4 Congenital Heart Disease Phenotypes.
2023cited by 9position: contributordoi
Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies.
2023cited by 6position: contributordoi
Transcription factor protein interactomes reveal genetic determinants in heart disease
Cell 2022cited by 84position: lastdoi
Transcription factor protein interactomes reveal genetic determinants in heart disease.
2022cited by 70position: contributordoi
Transient Cell Cycle Induction in Cardiomyocytes to Treat Subacute Ischemic Heart Failure.
2022cited by 62position: contributordoi
Transcription Factor GATA4 Regulates Cell Type-Specific Splicing Through Direct Interaction With RNA in Human Induced Pluripotent Stem Cell-Derived Cardiac Progenitors.
2022cited by 24position: contributordoi
Cold shock domain–containing protein E1 is a posttranscriptional regulator of the LDL receptor
Science Translational Medicine 2022cited by 21position: middledoi
Cold shock domain-containing protein E1 is a posttranscriptional regulator of the LDL receptor.
2022cited by 18position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 28 papers (2019–2026)Christine E. Seidman · Harvard University16 papers (2018–2023)Yu Huang · Gladstone Institutes12 papers (2012–2021)Bruce D. Gelb · New York Proton Center10 papers (2020–2023)Steven R. DePalma · Harvard University8 papers (2019–2023)Daniel Bernstein · Ruhr University Bochum8 papers (2020–2023)George A. Porter · Golisano Children's Hospital8 papers (2020–2023)Mauro W. Costa · Gladstone Institutes8 papers (2022–2026)Kathryn N. Ivey · Rapt Therapeutics (United States)7 papers (2012–2019)Rajan Jain · Penn Center for AIDS Research7 papers (2020–2024)Tomohiro Nishino · Gladstone Institutes7 papers (2021–2026)Angelo Pelonero · Gladstone Institutes7 papers (2021–2026)Ji‐Dong Fu · The Ohio State University Wexner Medical Center6 papers (2012–2016)Mark P. White · Gladstone Institutes6 papers (2012–2016)Timothy A. McKinsey · The Medical Center of Aurora6 papers (2017–2024)Casey A. Gifford · Norwegian Womens Public Health Association6 papers (2019–2026)Martina Brueckner · Yale University5 papers (2018–2022)Wendy K. Chung · Oregon Health & Science University5 papers (2018–2022)Christina V. Theodoris · Institute of Human Genetics5 papers (2015–2020)Elizabeth Goldmuntz · Children's Hospital of Philadelphia5 papers (2018–2022)